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Risk Factors and Patterns of Potentially Avoidable Readmission
in Patients With Cancer
Jacques D. Donze´, MD, MSc, Stuart Lipsitz, ScD, MSc, and Jeffrey L. Schnipper, MD, MPH
QUESTION ASKED: What are the risk factors associated with 30-day potentially avoidable
readmissions in patients with cancer?
SUMMARYANSWER: Almost 40%of patientswith cancer had a 30-day readmission, and almost
one third of these were deemed potentially avoidable. Risk factors included the number of
medications, liver disease, low sodium, and low hemoglobin level at discharge.
WHATWEDID: In a retrospective cohort of 2,916 patients discharged from the oncology division
of an academic tertiary medical center, we identified predictors of potentially avoidable 30-day
readmissions by using the SQLape algorithm and multivariable logistic regression.
WHAT WE FOUND: Among the cohort, 37.3% were readmitted within 30 days, and of these,
31.4% of all readmissions, 11.7% of the cohort, were considered potentially avoidable. Several
independent risk factors for potentially avoidable readmission were identified. Causes of readmission
were similar to the causes of the index readmission: neoplasm, infection, nutritional and metabolic
disorders, GI disorders, and renal failure.
BIAS, CONFOUNDING FACTOR(S), REAL-LIFE IMPLICATIONS: Although we were not able
to account for the stage of cancer, and we cannot prove preventability of readmissions in these
patients, the use of these easily available risk factors can help physicians to identify patients who
may benefit from intensive transitional care interventions.
The full version of this article
may be viewed online at
ascopubs.org/journal/jop
50 Volume 13 / Issue 1 / January 2017 n Journal of Oncology Practice Copyright © 2016 by American Society of Clinical Oncology
Original Contribution FOCUS ON QUALITY
Downloaded from ascopubs.org by University of Auckland Library on March 20, 2018 from 130.092.009.058
Copyright © 2018 American Society of Clinical Oncology. All rights reserved.
Bern University Hospital, Bern,
Switzerland; Brigham and Women’s






published online ahead of print at
ascopubs.org/journal/jop on October
27, 2016.
Risk Factors and Patterns of
Potentially Avoidable Readmission
in Patients With Cancer
Jacques D. Donze´, MD,MSc, Stuart Lipsitz, ScD, MSc, and Jeffrey L. Schnipper, MD,MPH
Abstract
Purpose
Patientswith cancer are particularly at risk for readmissionwithin30-days after discharge.
To identify the patients who might beneﬁt from more-intensive discharge interventions,
we identiﬁed the risk factors associated with 30-day potentially avoidable readmissions.
Methods and Materials
We included all consecutive discharges from the oncology division of an academic tertiary
medical center in Boston, Massachusetts, between July 1, 2009, and June 30, 2010.
Potentially avoidable 30-day readmissions to the index hospital and two other hospitals
within its network were identiﬁed. We performed a multivariable logistic regression in
which the ﬁnal model included variables found in bivariable testing to be signiﬁcantly
associated with the outcome.
Results
Among the 2,916 patients discharged during the study period, 1,086 (37.3%) were
readmitted within 30 days. Of these, 341 (31.4% of all readmissions, 11.7% of all
discharges) were identiﬁed as potentially avoidable. In the multivariable analysis, the
following patient factors were associated with a signiﬁcantly higher risk of a potentially
avoidable readmission: total number ofmedications at discharge, liver disease, last sodium
level, and last hemoglobin level before discharge. In addition, potentially avoidable
readmissions occurred signiﬁcantly earlier than unavoidable readmissions (median,
10 v 13 days; P , .001).
Conclusion
Almost 40% of patients with cancer had a 30-day readmission, and almost one third of
these were deemed potentially avoidable, and several risk factors for this were identiﬁed.
Interventions at discharge may be prioritized to patients with these risk factors.
INTRODUCTION
Avoidable hospital readmission is a widely
recognized problem within the modern
health care system because of its direct ef-
fects on patient outcomes and costs of care
andbecause it represents a natural target for
quality improvement efforts. Several studies
have identified specific factors associated
with hospital readmissions, but emerging
data have demonstrated that the nature
of the problem is both multifaceted and
complex. Underlying diagnoses as well as
comorbidities can influence the likelihood
of a patient’s hospital readmission in ways
that remain incompletely understood.1,2
Geriatric patients are at increased risk for
hospital readmission after an index hospi-
talization,3 but a recent study identified
e68 Volume 13 / Issue 1 / January 2017 n Journal of Oncology Practice Copyright © 2016 by American Society of Clinical Oncology
Original Contribution FOCUS ON QUALITY
Downloaded from ascopubs.org by University of Auckland Library on March 20, 2018 from 130.092.009.058
Copyright © 2018 American Society of Clinical Oncology. All rights reserved.
patients with cancer as another group at particular risk for
readmission within 30 days of hospital discharge.1
Evaluation of hospital readmissions within the oncology
patient population presents a particular challenge for several
reasons. First, many oncology hospitalizations are planned
for the administration of elective chemotherapy and do not
represent a failure of the system to prevent avoidable read-
missions. Second, patient comorbidities are key factors that
contribute to avoidable hospital readmissions.1 Oncology
patients may have multiple and complex comorbidities as a
result of not only the etiology of their malignancy but also the
expected, and thus incompletely preventable, complications
of treatment. Finally,many oncology patients will face end-of-
life decisions, another independently identified variable that
can contribute to potentially avoidable readmissions.4
Overall, oncology patients represent a large and growing
complex and medically vulnerable population. Identification
of specific risk factors associated with potentially avoidable
readmissions in this population may allow for more targeted
interventions to prevent readmissions and thereby improve
disease outcomes, quality of life, and cost-effective deliv-
ery of care. We used a retrospective cohort of consecutive
adult patient discharges from an academic tertiary hospital
with a large inpatient oncology census to identify specific
risk factors associated with 30-day potentially avoidable
readmissions.
METHODS AND MATERIALS
Study Design and Population
We included all consecutive adult patients discharged from
the oncology service of the Brigham and Women’s Hospital
(BWH)/Dana-Farber Cancer Institute (DFCI) between July 1,
2009, and June 30, 2010. BWH is a 750-bed academic medical
center in Boston, Massachusetts. DFCI is a National Cancer
Institute–designated Comprehensive Cancer Center. Since
1997, all DFCI inpatients are hospitalized within BWH.
Hospital stays of # 24 h were not included because they are
mainly observational stays. We excluded patients who died
before discharge of the index hospitalization, were transferred
to another acute health care facility, or left against medical ad-
vice. We excluded patients who died during the index
hospitalization because they were no longer at risk for
readmission, and we excluded patients who were transferred
to another health care facility because the risk of readmission
must be measured at the time of discharge from the second
facility and based on that facility’s data. The study protocol
was approved by the institutional review board of BWH/
Partners Healthcare.
Study Outcome
The study outcome was any 30-day potentially avoidable
readmission to any service of three hospitals within the Partners
Healthcare network, which were BWH,Massachusetts General
Hospital (a 1,000-bed tertiary care hospital), and Faulkner
Hospital (a 150-bed community hospital closely affiliated with
BWH). More than 80% of all readmissions after an index medi-
cal admission to BWH are captured within this network.5,6 We
identified readmissions deemed potentially avoidable with a
validated algorithm (SQLape, Corseaux, Switzerland) that uses
administrative data, mainly diagnostic and procedure codes of
both index admission and readmission.7,8 The algorithm ex-
cludes unavoidable foreseen readmissions, such as those for
chemotherapy or radiotherapy, transplantation, labor and
delivery, and other specific surgical procedures. Follow-up and
rehabilitation treatments also are considered unavoidable.
Readmissions for a disease that occurred in a new organ
system (eg, circulatory, respiratory, digestive, hepatic, ner-
vous, blood) not affected during the index hospitalization
were also considered unavoidable. Readmissions related
to specific difficult-to-cure diseases (eg, multiple sclerosis,
idiopathic thrombocytopenia) were considered unavoidable.
Conversely, complications of treatment, such as deep vein
thrombosis or catheter-associated urinary tract infection,
were considered potentially avoidable,8 as were other read-
missions that involve an organ system affected during the index
hospitalization. The sensitivity and the specificity of the
screening algorithm reached 96% compared with medical
chart review (with use of the same criteria) in a random
sample of admission-readmission pairs.9 We chose the SQLape
algorithm because it was the only available tool to our knowl-
edge that differentiates unavoidable from potentially avoidable
readmissions.
Predictor Variables
We collected data on several types of variables from easily
obtainable sources (Table 1), including demographic in-
formation, previous health care use, primary care provider
information, and index admission characteristics from ad-
ministrative data sources; procedures and chronic medical
conditions from billing data; and last known laboratory values
before discharge from the Partners Healthcare clinical data
Copyright © 2016 by American Society of Clinical Oncology Volume 13 / Issue 1 / January 2017 n ascopubs.org/journal/jop e69
Hospital Readmissions in Patients With Cancer
Downloaded from ascopubs.org by University of Auckland Library on March 20, 2018 from 130.092.009.058
Copyright © 2018 American Society of Clinical Oncology. All rights reserved.
Table 1. Baseline Characteristics and Bivariable Analysis
Characteristic No 30-Day Readmission, No. (%) 30-Day PAR, No. (%) P
No. of patients 1,830 341
Mean age (SD), years 61.0 (13.9) 60.0 (13.8) .62
Male sex 893 (48.8) 151 (44.3) .16
Ethnicity .59
Non-Hispanic white* 1,544 (84.4) 287 (84.2)
Non-Hispanic black 155 (8.5) 28 (8.2)
Hispanic 73 (4.0) 19 (5.6)
Other† 58 (3.2) 7 (2.1)
Language‡ .33
English* 1,720 (94.0) 322 (94.4)
Spanish 47 (2.6) 13 (3.8)
Other§ 63 (3.4) 6 (1.8)
Marital status .90
Currently married or partner* 1,147 (62.7) 209 (61.3)
Single or never married 341 (18.6) 66 (19.4)
Separated, divorced, widowed, or no answer 342 (18.7) 66 (19.4)
Primary insurance .33
Medicare 759 (41.5) 133 (39.0)
Medicaid 110 (6.0) 28 (8.2)
Private 960 (52.5) 180 (52.8)
Source of index admission .43
Direct from home of outpatient clinic 764 (41.7) 134 (39.3)
Emergency department* 837 (45.7) 156 (45.7)
Nursing home, rehabilitation, or other hospital 229 (12.5) 51 (15.0)
Median index hospitalization LOS (IQR), days 4 (3-7) 5 (3-8) .003
Median No. of hospitalizations in the past year (IQR) 1 (0-2) 1 (0-3) .02
Urgent/emergent index hospitalization 1,613 (88.1) 312 (91.5) .08
Identified caregiver at discharge 111 (6.1) 21 (6.2) .95
Mean No. of medications at discharge (SD) 10.5 (4.8) 11.8 (5.0) , .001
Opiate medication at discharge 1,005 (56.4) 223 (66.6) .001
Anticoagulation therapy at discharge 327 (18.4) 87 (26.0) .002
Median Elixhauser comorbidity index (IQR) 16 (9-28) 19 (9-34) .001
Mean hemoglobin level at discharge (SD), g/dL 10.3 (1.4) 10.0 (1.3) .002
Mean sodium level at discharge (SD), mEq/L 136.9 (3.7) 136.1 (3.7) , .001
Type of malignant neoplasm
Hematologic neoplasm 694 (37.9) 111 (32.6) .08
Metastatic neoplasm 877 (47.9) 189 (55.4) .02
Neuro 31 (1.7) 9 (2.6) .31
Head and neck 22 (1.2) 4 (1.2) .97
Pulmonary 201 (11.0) 36 (10.6) .81
GI 199 (10.9) 45 (13.2) .22
(continued on following page)
e70 Volume 13 / Issue 1 / January 2017 n Journal of Oncology Practice Copyright © 2016 by American Society of Clinical Oncology
Donze´, Lipsitz, and Schnipper
Downloaded from ascopubs.org by University of Auckland Library on March 20, 2018 from 130.092.009.058
Copyright © 2018 American Society of Clinical Oncology. All rights reserved.
repository. Variables were chosen a priori and according to
the medical literature.10-12
Comorbidities were retrieved from the index hospitaliza-
tion by using the following International Classification of
Diseases, Ninth Revision, Clinical Modification, codes: di-
abetes mellitus (249.00 to 250.99), congestive heart failure
(428.x, 425.4 to 425.9, 402.01, 402.11, and 398.91), ischemic
cardiac disease (410.00 to 414.99), atrial flutter/fibrillation
(427.30 to 427.32), chronic obstructive pulmonary disease
(491.00 to 492.99, 493.2, and 496), chronic kidney disease
(585.00 to 586.99), and liver disease (571.00 to 573.99).
Primary Diagnosis of Readmission
The primary diagnosis of each readmission was identified
by using the following Medicare Severity Diagnosis-Related
Groups codes: congestive heart failure (291 to 293, 189),
chronic obstructive pulmonary disease (190 to 192), cardiac
ischemic disease (231 to 236, 246 to 251, 280 to 285), ar-
rhythmia (308 to 310), cerebrovascular diseases (061 to 072),
adverse drug events (917 to 923), renal failure (682 to 685),
nutritional and metabolic disorders (640 to 641), venous
thromboembolism(175to176,294 to295), liverdisorders(405
to 434, 438 to 446), GI disorders (391 to 392, 377 to 384),
infectious diseases (075 to 076, 094 to 099, 121 to 122, 177 to
179, 193 to 195, 371 to 373, 485 to 489, 548 to 550, 689 to 690,
757 to 759, 853 to 863, 865 to 872), and neoplasm (054 to 055,
146 to 148, 180 to 182, 374 to 376, 435 to 437, 582 to 583, 597 to
599, 656 to 658, 686 to 688, 715 to 724, 736 to 741, 754 to 756,
846 to 849).
Statistical Analysis
Patient baseline characteristics are presented as proportions,
means with standard deviations, andmedians with interquartile
ranges (IQRs) as appropriate. The unit of analysis was any pa-
tient’s index discharge from the oncology service.
The presence of any difference in baseline character-
istics between the groups with a 30-day potentially avoidable
readmission and those not readmitted at all was first tested
by bivariable logistic regression. We then performed a mul-
tivariable logistic regression in which the final model included
variables found to be significantly associated with the out-
come in bivariable testing at the P = .05 level. The time to
Table 1. Baseline Characteristics and Bivariable Analysis (continued)
Characteristic No 30-Day Readmission, No. (%) 30-Day PAR, No. (%) P
Renal 30 (1.6) 7 (2.1) .61
Gynecologic 48 (2.6) 17 (5.0) .07
Pancreatic 52 (2.8) 14 (4.1) .21
Selected comorbidities
Diabetes mellitus 280 (15.3) 55 (16.1) .72
Congestive heart failure 101 (5.5) 29 (8.5) .05
Ischemic heart disease 182 (9.9) 39 (11.4) .46
Atrial fibrillation 125 (5.8) 28 (1.3) .39
Chronic obstructive pulmonary disease 124 (6.8) 25 (7.3) .68
Chronic kidney disease 106 (5.8) 20 (5.9) .96
Liver disease 54 (3.0) 16 (4.7) .07
Most frequent reasons of the index admission .37
Neoplasm 435 (23.8) 66 (19.4)
Infectious disease 203 (11.1) 29 (8.5)
GI disorder 93 (5.1) 15 (4.4)
Nutritional and metabolic disorder 81 (4.4) 17 (5.0)
Liver disorder 39 (2.1) 7 (2.1)
Renal failure 35 (1.9) 9 (2.6)
Venous thromboembolism 33 (1.8) 6 (1.8)
Abbreviations: IRQ, interquartile range; LOS, length of stay; PAR, potentially avoidable readmission; SD, standard deviation.
*Reference group for the multivariable logistic regression.
†Includes Asian, Pacific Islander, Native American, and Alaskan Native.
‡Preferred language based on hospital administrative data.
§Includes Chinese and French.
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readmission within the 30-day frame is presented as median
with IQR.
All tests were conducted as two sided at a .05 level of
significance. Analyses were performed with SAS 9.3 statistical
software (SAS Institute, Cary, NC).
RESULTS
Among the 3,505 patients discharged from the oncology di-
vision, 399 were excluded because they were transferred to
another acute health care facility, 185 because they died, and
five because they left against medical advice. Of the remaining
2,916 patient discharges, 1,086 (37.3%) were followed by a
readmission within 30 days. Of these, 341 (31.4% of all
readmissions, 11.7% of all discharges) were identified as po-
tentially avoidable (Appendix Fig A1, online only). Table 1
compares the baseline characteristics between the patients
who did not have a 30-day readmission and those who had a
30-day potentially avoidable readmission.
From the bivariable analysis, the following factors were
associated with a 30-day potentially avoidable readmission at
the .10 significance level: length of stay, number of admis-
sions in the previous 12 months, urgent or emergent index
hospitalization, total number of medications on discharge,
opiate medication use at discharge, anticoagulation at dis-
charge, Elixhauser comorbidity index, hemoglobin level at
discharge, sodium level at discharge, hematologic neoplasm,
metastatic neoplasm, ovarian neoplasm, congestive heart
failure, and liver disease. In the multivariable analysis, the
following risk factors remained significantly and inde-
pendently associated with a potentially avoidable read-
mission: total number of medications at discharge, liver
disease, sodium level at discharge, and hemoglobin level
at discharge (Table 2).
The five most frequent primary diagnoses at readmission
were neoplasm, infection, nutritional and metabolic disorder,
GIdisorder, andrenal failure (Table 3). Of note, thesewere five
of the top six primary diagnoses for the index hospitalization
(Table 1). Themedian timeof occurrence of 30-daypotentially
avoidable readmissions was 10 (IQR, 9 to 11) days versus 13
(IQR, 12 to 14) days for 30-day unavoidable readmissions
(P, .001). The median time of 30-day potentially avoidable
readmission varied from 4 to 12 days according to the primary
diagnosis of readmission (Table 3). Readmissions due to adverse
drug events, GI disorders, renal failure, or infection tended to
Table 2. Multivariable Analysis of Risk Factors for 30-Day Potentially Avoidable Readmission in Patients With Cancer
Variable Odds Ratio (95% CI) P
Length of stay, per 1-day increase 1.01 (1.00 to 1.02) .32
Urgent/emergent index hospitalization 1.34 (0.82 to 2.19) .24
No. of admissions in the previous year* 1.05 (0.99 to 1.12) .10
Total No. of medications at discharge* 1.03 (1.01 to 1.06) .02†
Opiate medication at discharge 1.20 (0.88 to 1.62) .25
Anticoagulation therapy at discharge 1.36 (0.99 to 1.85) .05
Elixhauser comorbidity index, per 1-unit increase 1.00 (0.99 to 1.01) .96
Congestive heart failure 1.58 (0.96 to 2.59) .07
Liver disease 1.75 (1.02 to 3.00) .04†
Hematologic neoplasm 1.08 (0.73 to 1.62) .70
Metastatic neoplasm 1.26 (0.82 to 1.95) .29
Ovarian neoplasm 1.88 (0.88 to 4.00) .10
Hemoglobin, per 1 mmol/L decrease 1.14 (1.03 to 1.25) .01†
Sodium level, per 1 mmol/L decrease 1.04 (1.00 to 1.07) .03†
*Per 1-unit increase.
†Statistically significant.
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occur earlier, whereas readmissions due to nutritional or met-
abolic disorders, heart failure, and thrombosis occurred later.
DISCUSSION
In this cohort of 2,916 patients with cancer, we found that
almost 40% were readmitted within 30 days and that ap-
proximately one third of these readmissions were considered
potentially preventable. Several factors were identified as
independently associated with 30-day potentially avoidable
readmission, including the total number of medications at
discharge, liver disease, last sodium level, and last hemoglobin
level before discharge. Of note, potentially avoidable read-
missions occurred significantly earlier than unavoidable read-
missions, with time to readmission varying substantially according
to the readmission diagnosis.
Patients with cancer have a particularly high risk for
readmission,2,13 but the characteristics of this population are
not clear. The majority of the studies on readmission among
patients with cancer looked at surgical patients with post-
operative readmission for specific cancers.14-19 Much less is
known about the readmission characteristics for general pa-
tients with cancer hospitalized within a medical or oncology
service.20-22
Many of the potentially avoidable readmissions in this
study simply represent progression of disease or unavoid-
able adverse effects of treatment (and thus, are not truly
preventable). However, as in other studies that used the
SQLape algorithm, those with potentially avoidable read-
missions should be thought of as a population enriched for
patients whose readmissions might have been prevented with
more-intensive transitional care activities.
The risk factors identified in this study seem plausible. The
total number of medications likely represents a proxy for
patientcomorbiditiesand/orhigherrisk for readmissiondueto
adverse drug events. Liver disease in patients with cancer may
representmetastatic disease, which carries a poor prognosis as
well as a risk for bleeding, infection, hepatic encephalopathy,
and other complications of cirrhosis. Low sodium level is as-
sociated with poor outcomes in many disease states23-26 and
may reflect a higher risk due to comorbidities that cause
hyponatremia (eg, heart failure), chemotherapy-induced dehy-
dration, or syndrome of inappropriate antidiuretic hormone
secretiondue to total cancerburdenor lungorbrain involvement.
Finally, a low hemoglobin may reflect bonemarrow suppression
associated with certain chemotherapies, poor nutritional status,
and/or anemia of chronic inflammation. Most of these risk
factors are notmodifiable, however, andwe do not imply that by
addressing these risk factors themselves, even if they are mod-
ifiable, postdischarge outcomes would be improved. However,
these risk factors identify patients who may benefit from in-
tensive transitional care interventions.
The study has several limitations. First, we included in the
analysis only predictors easily obtainable from electronic data
sources. We cannot exclude the presence of other important
risk factors for readmission, such as the functional status of
the patient. In addition, we were not able to capture the stage of
the cancer. On the basis of the available data, we show that
metastaticneoplasmwasnot an independent risk factor for 30-
day potentially avoidable readmission in multivariable anal-
ysis. This finding suggests that the stage may not be as im-
portant as expected, but we acknowledge that this coding is an
imperfect proxy for cancer stage and that further studies are
needed to explore this particular relationship. Second, no gold
standard is available for the definition of preventable read-
mission. The identification of potentially avoidable read-
missionwith the SQLape algorithm is not perfect, andwhether
the algorithm is any more or less diagnostic for oncology
patients than any other category of hospitalized medical pa-
tients is unknown. However, SQLape has been used in nu-
merous other studies; uses clear and logical criteria, which
allow for reproducibility and reliability in the analysis of large
databases; and is useful for identifying risk factors. The study
Table 3. Median Time of Readmission According to the
Cause of 30-Day Potentially Avoidable Readmissions
(n = 341)
Primary Diagnosis of Readmission No. (%)
Median Time of
Readmission (IQR)
Neoplasm 67 (19.7) 10 (4-19)
Infection 45 (13.2) 9 (4-14)
Nutritional or metabolic disorder 17 (5.0) 11 (6-14)
GI disorder 16 (4.7) 6.5 (4-14)
Renal failure 11 (3.2) 8 (4-17)
Arterial or venous thrombosis 5 (1.5) 14 (14-19)
Adverse drug event 5 (1.5) 6 (6-17)
Heart failure 3 (0.9) 12 (4-26)
Other 172 (50.4) 11 (5-17)
Abbreviation: IQR, interquartile range.
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may have been underpowered to identify all clinically im-
portant risk factors. We do not have information to draw
conclusions about whether the risk factors for potentially
avoidable readmission differ for patients readmitted to a
different hospital from the site of their index hospitalization.
Finally, this single-center studywas fromanacademic hospital
with a major cancer institute, and results might not be gen-
eralizable to other settings. Next steps could include detailed
medical record review to determine the true preventability of
these readmissions, identify potentially actionable risk factors
unique to this population, and better understand the differ-
ences in time to readmission among various populations.
In conclusion, readmission in this large cohort of patients
with cancer was frequent, with approximately one third of
readmissions deemed potentially preventable. Risk factors
associated with 30-day potentially avoidable readmission are
the number of medications, liver disease, and low sodium and
hemoglobin levels.Patientsdischargedwith these factorscould
benefit from transitional care interventions.
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FIG A1. Study flow diagram describing the readmissions of all consecutive
discharges from the oncology division of an academic tertiary medical
center in Boston, MA, between July 1, 2009, and June 30, 2010.
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